These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 26150437

  • 1. Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men.
    Skoglund PH, Höijer J, Ärnlöv J, Zethelius B, Svensson P.
    Hypertension; 2015 Sep; 66(3):681-6; discussion 445. PubMed ID: 26150437
    [Abstract] [Full Text] [Related]

  • 2. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH, Arpegård J, Ostergren J, Svensson P.
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [Abstract] [Full Text] [Related]

  • 3. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
    Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.
    Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
    [Abstract] [Full Text] [Related]

  • 4. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study.
    Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, Breteler MM, Witteman JC, van den Meiracker AH.
    Hypertension; 2010 Mar; 55(3):785-91. PubMed ID: 20083731
    [Abstract] [Full Text] [Related]

  • 5. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Svennberg E, Lindahl B, Berglund L, Eggers KM, Venge P, Zethelius B, Rosenqvist M, Lind L, Hijazi Z.
    Int J Cardiol; 2016 Nov 15; 223():74-81. PubMed ID: 27541645
    [Abstract] [Full Text] [Related]

  • 6. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 15; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 7. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.
    J Hypertens; 2006 Aug 15; 24(8):1531-9. PubMed ID: 16877955
    [Abstract] [Full Text] [Related]

  • 8. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M, Bhatt DL, Vaduganathan M, Biering-Sørensen T, Qamar A, Diederichsen AC, Møller JE, Hindersson P, Leósdóttir M, Magnusson M, Nilsson PM, Olsen MH.
    Eur J Prev Cardiol; 2017 Oct 15; 24(15):1648-1659. PubMed ID: 28644092
    [Abstract] [Full Text] [Related]

  • 9. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
    van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, Roe MT, Ezekowitz JA, Moliterno DJ, Neumann FJ, Reist C, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Granger CB, Theroux P, APEX AMI Investigators.
    Int J Cardiol; 2013 Oct 03; 168(3):2127-33. PubMed ID: 23394896
    [Abstract] [Full Text] [Related]

  • 10. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M.
    Clin J Am Soc Nephrol; 2015 Feb 06; 10(2):205-14. PubMed ID: 25605700
    [Abstract] [Full Text] [Related]

  • 11. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J.
    N Engl J Med; 2008 May 15; 358(20):2107-16. PubMed ID: 18480203
    [Abstract] [Full Text] [Related]

  • 12. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P, Balmelli C, Reichlin T, Twerenbold R, Reiter M, Meissner J, Schaub N, Stelzig C, Freese M, Paniz P, Meune C, Drexler B, Freidank H, Winkler K, Hochholzer W, Mueller C.
    Am J Med; 2011 Aug 15; 124(8):731-9. PubMed ID: 21787902
    [Abstract] [Full Text] [Related]

  • 13. Prognostic Value of Cardiovascular Biomarkers in the Population.
    Neumann JT, Twerenbold R, Weimann J, Ballantyne CM, Benjamin EJ, Costanzo S, de Lemos JA, deFilippi CR, Di Castelnuovo A, Donfrancesco C, Dörr M, Eggers KM, Engström G, Felix SB, Ferrario MM, Gansevoort RT, Giampaoli S, Giedraitis V, Hedberg P, Iacoviello L, Jørgensen T, Kee F, Koenig W, Kuulasmaa K, Lewis JR, Lorenz T, Lyngbakken MN, Magnussen C, Melander O, Nauck M, Niiranen TJ, Nilsson PM, Olsen MH, Omland T, Oskarsson V, Palmieri L, Peters A, Prince RL, Qaderi V, Vasan RS, Salomaa V, Sans S, Smith JG, Söderberg S, Thorand B, Tonkin AM, Tunstall-Pedoe H, Veronesi G, Watanabe T, Watanabe M, Zeiher AM, Zeller T, Blankenberg S, Ojeda F.
    JAMA; 2024 Jun 11; 331(22):1898-1909. PubMed ID: 38739396
    [Abstract] [Full Text] [Related]

  • 14. B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women.
    Everett BM, Berger JS, Manson JE, Ridker PM, Cook NR.
    J Am Coll Cardiol; 2014 Oct 28; 64(17):1789-97. PubMed ID: 25443700
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P.
    Atherosclerosis; 2013 Jun 28; 228(2):478-84. PubMed ID: 23582589
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.
    J Hypertens; 2008 Jan 28; 26(1):26-34. PubMed ID: 18090537
    [Abstract] [Full Text] [Related]

  • 17. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.
    Hussain A, Sun W, Deswal A, de Lemos JA, McEvoy JW, Hoogeveen RC, Matsushita K, Aguilar D, Bozkurt B, Virani SS, Shah AM, Selvin E, Ndumule C, Ballantyne CM, Nambi V.
    J Am Coll Cardiol; 2021 Feb 09; 77(5):559-571. PubMed ID: 33538254
    [Abstract] [Full Text] [Related]

  • 18. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E, Wuppinger T, Bode T, Alber H, Ulmer H, Pachinger O, Mair J.
    Coron Artery Dis; 2012 Mar 09; 23(2):91-7. PubMed ID: 22157356
    [Abstract] [Full Text] [Related]

  • 19. N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.
    Welsh P, Doolin O, Willeit P, Packard C, Macfarlane P, Cobbe S, Gudnason V, Di Angelantonio E, Ford I, Sattar N.
    Eur Heart J; 2013 Feb 09; 34(6):443-50. PubMed ID: 22942340
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 May 09; 19(3):187-93. PubMed ID: 18418236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.